Medicine
Carisoprodol 250 mg tablet
Carisoprodol 250 mg tablet is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Carisoprodol
- Brand
- Sold under the generic name
- Strength
- 250 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 30 tablets, 60 tablets and 12 more
- Manufacturers
- Aurobindo PharmaIndiaAsclemedBryant Ranch PrepackMylan PharmaceuticalsRising Pharma HoldingsWestminster PharmaceuticalsWilshire Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CIV
- ATC code
- M03BA02 Carisoprodol
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 October 2016
- Identifiers
- RxCUI 197446, 730794DailyMed set ID f03a1ea6-20c1-406a-a5b6-00f1a056d9ff, 7c9184c0-7a2e-11df-8c8d-0002a5d5c51b, 8079db44-70d4-4daf-b4b7-89d0e0f38470 +5NDC 52536-682, 51525-5901, 63629-9144 +5Application ANDA205126, NDA011792, ANDA207237 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 65862-693-01 | Aurobindo PharmaIndia | 8 November 2016 |
| 30 tablet in 1 bottle | 65862-693-30 | Aurobindo PharmaIndia | 8 November 2016 |
| 60 tablet in 1 bottle | 65862-693-60 | Aurobindo PharmaIndia | 8 November 2016 |
| 90 tablet in 1 bottle | 65862-693-90 | Aurobindo PharmaIndia | 8 November 2016 |
| 1000 tablet in 1 bottle | 65862-693-99 | Aurobindo PharmaIndia | 8 November 2016 |
| 100 tablet in 1 bottle | 51525-5901-1 | Mylan Pharmaceuticals | 1 October 2016 |
| 100 tablet in 1 bottle | 16571-780-01 | Rising Pharma Holdings | 8 November 2016 |
| 100 tablet in 1 bottle | 52536-682-10 | Wilshire Pharmaceuticals | 15 February 2017 |
| 100 tablet in 1 bottle | 63629-9144-1 | Bryant Ranch Prepack | 26 January 2022 |
| 100 tablet in 1 bottle | 71335-2708-1 | Bryant Ranch Prepack | 28 July 2025 |
| 100 tablet in 1 bottle | 76420-852-01 | Asclemed | 12 September 2024 |
| 30 tablet in 1 bottle | 76420-852-30 | Asclemed | 12 September 2024 |
| 60 tablet in 1 bottle | 76420-852-60 | Asclemed | 12 September 2024 |
| 90 tablet in 1 bottle | 76420-852-90 | Asclemed | 12 September 2024 |
| 100 tablet in 1 bottle | 69367-419-01 | Westminster Pharmaceuticals | 25 November 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 9 April 1959 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Carisoprodol 250 mg tablet.
Other strengths and forms of Carisoprodol
Clinical summary
Carisoprodol is a muscle relaxant indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. It is available as tablets for oral use. MedsAcross supplies Carisoprodol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CarisoprodolFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Soma prescribing information (Viatris Specialty) · U.S. National Library of Medicine, DailyMed
Need Carisoprodol 250 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.